Early Investigator Research Award – HT9425-23-PRP-EIRA
- up to USD$500,000 over 2 years
- letters of intent due 27 July 2023
- postdoctoral, clinical fellows, assistant professors within 10 years of PhD or residency training
- Supports research opportunities for investigators in the early stages of their careers, under the guidance of one or two designated Mentor(s).
- Mentor(s) must have experience in Parkinson’s Disease research and mentoring
- must address at least one of the FY23 Focus Areas
- preliminary data encouraged but not required
- clinical trials not allowed
Investigator-Initiated Research Award – HT9425-23-PRP-IIRA
- up to USD$1.5M over 3 years
- letters of intent due 27 July 2023
- Supports highly rigorous, multidisciplinary, high- impact research projects that have the potential to make an important contribution to Parkinson’s research.
- supports the full spectrum of research from basic science through clinical research.
- must address at least one of the FY23 Focus Areas.
- Preliminary data to support feasibility encouraged but not required
- clinical trials allowed
Synergistic Idea Award – HT9425-23-PRP-SIA
- up to USD$3M over 4 years
- letters of intent due 27 July 2023
- Supports new ideas that represent synergistic approaches to PD research involving two or four PIs.
- Investigators should utilize their complementary and synergistic perspectives to address a central problem or question in Parkinson’s research.
- designed to support both new and pre-existing partnerships and encourages participation of PIs from other research fields.
- must address at least one of the FY23 Focus Areas.
- Preliminary data to support feasibility encouraged but not required.
- clinical trials allowed
23FY Focus Areas
- Biological mechanisms or biomarkers, including biologically informed clinical evaluations, of non-motor symptoms that could lead to the development of treatments for PD. Applications focused on laboratory models through to human subjects, including computational approaches, would be considered. Examples of non-motor symptoms of interest include, but are not limited to:
- Cognitive dysfunction relevant to PD
- Psychiatric dysfunction
- Sleep and circadian rhythms disruptions
- Autonomic dysfunction
- Sensory dysfunction
- Other non-motor symptoms including fatigue, apathy, and impulse control disorders
- Biological mechanisms or biomarkers associated with non-pharmacological interventions for PD. Examples of non-pharmacological interventions of interest include:
- Exercise
- Diet
- Neuro-stimulation therapy
- Neurosurgical
Supporting documents for download
- Reference Table of Award Mechanisms – 23prpreftable
- Early Investigator Research Award – HT9425-23-PRP-EIRA-GG
- Investigator-Initiated Research Award – HT9425-23-PRP-IIRA-GG
- Synergistic Idea Award – HT9425-23-PRP-SIA-GG